PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2950.0
(-2.64%)
IDR 2950.0
(-2.64%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2934.42 Billion IDR | 12.25% |
| 2022 | 2614.08 Billion IDR | -5.98% |
| 2021 | 2780.38 Billion IDR | 15.4% |
| 2020 | 2409.41 Billion IDR | 37.36% |
| 2019 | 1754.1 Billion IDR | 27.27% |
| 2018 | 1378.26 Billion IDR | 7.45% |
| 2017 | 1282.75 Billion IDR | 18.05% |
| 2016 | 1086.61 Billion IDR | -12.81% |
| 2015 | 1246.31 Billion IDR | 4.7% |
| 2014 | 1190.41 Billion IDR | 23.77% |
| 2013 | 961.78 Billion IDR | -28.31% |
| 2012 | 1341.58 Billion IDR | 43.72% |
| 2011 | 933.44 Billion IDR | 45.5% |
| 2010 | 641.56 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3364.77 Billion IDR | 14.67% |
| 2024 Q3 | 3279.28 Billion IDR | -5.71% |
| 2024 Q2 | 3477.88 Billion IDR | 3.36% |
| 2023 Q3 | 3063.57 Billion IDR | -2.29% |
| 2023 Q4 | 2934.42 Billion IDR | -4.22% |
| 2023 FY | 2934.42 Billion IDR | 12.25% |
| 2023 Q1 | 2887.45 Billion IDR | 10.46% |
| 2023 Q2 | 3135.31 Billion IDR | 8.58% |
| 2022 Q3 | 2568.47 Billion IDR | -2.24% |
| 2022 FY | 2614.08 Billion IDR | -5.98% |
| 2022 Q1 | 2860.21 Billion IDR | 2.87% |
| 2022 Q2 | 2627.34 Billion IDR | -8.14% |
| 2022 Q4 | 2614.08 Billion IDR | 1.78% |
| 2021 Q1 | 2704.87 Billion IDR | 12.26% |
| 2021 Q3 | 2553.26 Billion IDR | -3.01% |
| 2021 Q2 | 2632.53 Billion IDR | -2.67% |
| 2021 Q4 | 2780.38 Billion IDR | 8.9% |
| 2021 FY | 2780.38 Billion IDR | 15.4% |
| 2020 FY | 2409.41 Billion IDR | 37.36% |
| 2020 Q1 | 2952.7 Billion IDR | 68.33% |
| 2020 Q4 | 2409.41 Billion IDR | -14.17% |
| 2020 Q3 | 2807.17 Billion IDR | 0.06% |
| 2020 Q2 | 2805.5 Billion IDR | -4.99% |
| 2019 Q1 | 1555.31 Billion IDR | 12.85% |
| 2019 Q4 | 1754.1 Billion IDR | 8.55% |
| 2019 Q3 | 1615.97 Billion IDR | 7.15% |
| 2019 FY | 1754.1 Billion IDR | 27.27% |
| 2019 Q2 | 1508.08 Billion IDR | -3.04% |
| 2018 Q4 | 1378.26 Billion IDR | -0.84% |
| 2018 FY | 1378.26 Billion IDR | 7.45% |
| 2018 Q3 | 1389.92 Billion IDR | -0.96% |
| 2018 Q2 | 1403.39 Billion IDR | 4.46% |
| 2018 Q1 | 1343.54 Billion IDR | 4.74% |
| 2017 Q2 | 1181.11 Billion IDR | -1.49% |
| 2017 Q4 | 1282.75 Billion IDR | -3.07% |
| 2017 Q3 | 1323.42 Billion IDR | 12.05% |
| 2017 FY | 1282.75 Billion IDR | 18.05% |
| 2017 Q1 | 1198.93 Billion IDR | 10.34% |
| 2016 Q1 | 1378.99 Billion IDR | 10.65% |
| 2016 FY | 1086.61 Billion IDR | -12.81% |
| 2016 Q4 | 1086.61 Billion IDR | -26.17% |
| 2016 Q3 | 1471.78 Billion IDR | 2.79% |
| 2016 Q2 | 1431.83 Billion IDR | 3.83% |
| 2015 Q4 | 1246.31 Billion IDR | -4.85% |
| 2015 Q3 | 1309.84 Billion IDR | 2.41% |
| 2015 Q2 | 1279.01 Billion IDR | 2.39% |
| 2015 Q1 | 1249.11 Billion IDR | 4.93% |
| 2015 FY | 1246.31 Billion IDR | 4.7% |
| 2014 Q2 | 958.93 Billion IDR | -1.01% |
| 2014 Q3 | 1166.2 Billion IDR | 21.61% |
| 2014 Q4 | 1190.41 Billion IDR | 2.08% |
| 2014 FY | 1190.41 Billion IDR | 23.77% |
| 2014 Q1 | 968.74 Billion IDR | 0.72% |
| 2013 Q3 | 1087.46 Billion IDR | 0.0% |
| 2013 FY | 961.78 Billion IDR | -28.31% |
| 2013 Q1 | 1389.72 Billion IDR | 3.59% |
| 2013 Q4 | 961.78 Billion IDR | -11.56% |
| 2012 Q4 | 1341.58 Billion IDR | 0.0% |
| 2012 FY | 1341.58 Billion IDR | 43.72% |
| 2011 FY | 933.44 Billion IDR | 45.5% |
| 2010 FY | 641.56 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Bundamedik Tbk | 1283.12 Billion IDR | -128.693% |
| PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | -182.351% |
| PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | 18.586% |
| PT Mitra Keluarga Karyasehat Tbk | 741.05 Billion IDR | -295.977% |
| PT Murni Sadar Tbk | 708.74 Billion IDR | -314.031% |
| PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | -65.838% |
| PT Royal Prima Tbk | 49.68 Billion IDR | -5806.011% |
| PT Kedoya Adyaraya Tbk | 77.63 Billion IDR | -3679.827% |
| PT Sarana Meditama Metropolitan Tbk | 1381.15 Billion IDR | -112.461% |
| PT Sejahteraraya Anugrahjaya Tbk | 3748.83 Billion IDR | 21.724% |